Advertisement

Topics

#Innovent Presents Clinical Data of Anti-PD-1 Antibody Sintilimab in Patients with First-line Squamous #NSCLC at Asia Conference on Lung Cancer 2018 https://www.prnewswire.com/news-releases/innovent-presents-clinical-data-of-anti-pd-1-antibody-sintilimab-

05:25 EST 9 Nov 2018 | Odi Bruckman

Presents Clinical Data of Anti-PD-1 Antibody Sintilimab in Patients with First-line Squamous at Asia Conference on Lung Cancer 2018 https://www.prnewswire.com/news-releases/innovent-presents-clinical-data-of-anti-pd-1-antibody-sintilimab-in-patients-with-first-line-squamous-nsclc-at-asia-conference-on-lung-cancer-2018-300747389.html …

Original Article: #Innovent Presents Clinical Data of Anti-PD-1 Antibody Sintilimab in Patients with First-line Squamous #NSCLC at Asia Conference on Lung Cancer 2018 https://www.prnewswire.com/news-releases/innovent-presents-clinical-data-of-anti-pd-1-antibody-sintilimab-

NEXT ARTICLE

More From BioPortfolio on "#Innovent Presents Clinical Data of Anti-PD-1 Antibody Sintilimab in Patients with First-line Squamous #NSCLC at Asia Conference on Lung Cancer 2018 https://www.prnewswire.com/news-releases/innovent-presents-clinical-data-of-anti-pd-1-antibody-sintilimab-"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Lung Cancer
Lung cancer is the uncontrolled cell growth in tissues of the lung. Originating in the lungs, this growth may invade adjacent tissues and infiltrate beyond the lungs. Lung cancer, the most common cause of cancer-related death in men and women, is respons...